CG:NASDAQThe Carlyle Group Inc. Analysis
Data as of 2026-09-02 - not real-time
$46.54
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The Carlyle Group Inc. trades at $46.54, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Over a rolling month the price has gained 4.3%. With RSI at 43.4 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near $46.16 and resistance around $52.16.
Valuation screens as fair: a P/E of 48.5 sits above the sector average of 16.7. The average analyst target implies 25.0% above today's level. Revenue is contracting at 32.9% on a 13.0% profit margin. The 2.89% dividend yield looks stretched against payout coverage.
The composite risk read is 8/10, putting it in high territory. With 30-day volatility of 40.7%, a beta of 1.57 and a maximum drawdown of 41.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 3 out of 10.
Valuation screens as fair: a P/E of 48.5 sits above the sector average of 16.7. The average analyst target implies 25.0% above today's level. Revenue is contracting at 32.9% on a 13.0% profit margin. The 2.89% dividend yield looks stretched against payout coverage.
The composite risk read is 8/10, putting it in high territory. With 30-day volatility of 40.7%, a beta of 1.57 and a maximum drawdown of 41.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 3 out of 10.
Top Market Events
NEW YORK, Aug. 06, 2026 GLOBE NEWSWIRE -- Carlyle Secured Lending, Inc. together with its consolidated subsidiaries,...NEW YORK, July 15, 2026 GLOBE NEWSWIRE -- Carlyle Secured Lending, Inc.Private equity firm Carlyle Group NASDAQ:CG in Q2 CY2026, with sales up 14.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Trading below the 200-day average of 51.00
- MACD momentum is negative
- 30-day volatility of 40.7%
Medium Term
1–3 yearsCautious
Model confidence: 4/10
Key Factors
- P/E of 48.5 versus sector average of 16.7
- Dividend yield of 2.89% looks stretched against payout coverage
- Trading below the 200-day average of 51.00
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 48.5 versus sector average of 16.7
- Dividend yield of 2.89% looks stretched against payout coverage
- Analyst targets imply +25.0% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth-32.90%
Profit Margin13.01%
P/E Ratio48.5
ROE7.77%
ROA2.03%
Debt/Equity197.62
P/B Ratio3.1
Op. Cash Flow$-3997499904
Industry P/E16.7
Technical Analysis
TrendNeutral
RSI43.4
Support$46.16
Resistance$52.16
MA 20$48.78
MA 50$46.21
MA 200$51.00
MACDBearish
VolumeDecreasing
Fear & Greed Index92.25
Valuation
Target Price$58.18
Upside/Downside25.00%
GradeFair
TypeBlend
Dividend Yield2.89%
Risk Assessment
Beta1.57
Volatility40.67%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.